Redeye: Vitec Q4 2024 - Solid y/y improvement in cash conversion
Redeye updates its estimates and valuation following Vitec releasing its Q4 2024 report. Fourth-quarter figures beat our top-line estimates, while EBITA came in slightly below what we pencilled in. Encouragingly, free cash flow to equity has roughly doubled over the last year. We expect Vitec to deliver solid organic growth and moderate acquired growth in 2025e. We update our estimates and raise our base case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/